DK1380303T3 - Kombinationsterapi til behandling af hepatitis B-virus - Google Patents
Kombinationsterapi til behandling af hepatitis B-virusInfo
- Publication number
- DK1380303T3 DK1380303T3 DK03077542T DK03077542T DK1380303T3 DK 1380303 T3 DK1380303 T3 DK 1380303T3 DK 03077542 T DK03077542 T DK 03077542T DK 03077542 T DK03077542 T DK 03077542T DK 1380303 T3 DK1380303 T3 DK 1380303T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- combination
- alternation
- administering
- directed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10666498P | 1998-11-02 | 1998-11-02 | |
PCT/US1999/025673 WO2000025797A1 (en) | 1998-11-02 | 1999-11-02 | Combination therapy to treat hepatitis b virus |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1380303T3 true DK1380303T3 (da) | 2008-12-01 |
Family
ID=22312611
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03077542T DK1380303T3 (da) | 1998-11-02 | 1999-11-02 | Kombinationsterapi til behandling af hepatitis B-virus |
DK03077543.1T DK1382343T3 (da) | 1998-11-02 | 1999-11-02 | Kombinationsterapi til behandling af hepatitis B-virus |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03077543.1T DK1382343T3 (da) | 1998-11-02 | 1999-11-02 | Kombinationsterapi til behandling af hepatitis B-virus |
Country Status (16)
Country | Link |
---|---|
US (3) | US6528515B1 (da) |
EP (3) | EP1380303B1 (da) |
JP (2) | JP2002528508A (da) |
KR (1) | KR100632520B1 (da) |
CN (3) | CN1173705C (da) |
AT (3) | ATE457734T1 (da) |
AU (1) | AU1810600A (da) |
CY (2) | CY1108635T1 (da) |
DE (3) | DE69923338T2 (da) |
DK (2) | DK1380303T3 (da) |
ES (3) | ES2237189T3 (da) |
HK (1) | HK1062146A1 (da) |
ID (1) | ID29471A (da) |
IL (3) | IL142910A0 (da) |
PT (2) | PT1382343E (da) |
WO (1) | WO2000025797A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1382343E (pt) * | 1998-11-02 | 2010-03-10 | Gilead Sciences Inc | Terapia de combinação para tratamento do vírus da hepatite b |
ES2345099T3 (es) * | 2002-06-19 | 2010-09-15 | Fideline | Feromonas tranquilizantes aviarias para disminuir el estres, la ansiedad y la agresividad. |
CA2492554A1 (en) * | 2002-07-15 | 2004-01-22 | Gilead Sciences, Inc. | Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
WO2004064846A1 (en) * | 2003-01-14 | 2004-08-05 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
WO2011145808A2 (ko) * | 2010-05-18 | 2011-11-24 | 부광약품 주식회사 | 클레부딘 및 아데포비어 디피복실을 함유하는 만성 b형 간염 치료용 조성물 |
KR20100127180A (ko) * | 2009-05-25 | 2010-12-03 | 부광약품 주식회사 | 클레부딘 및 아데포비어 디피복실을 함유하는 만성 b형 간염 치료용 조성물 |
CA2819548C (en) | 2010-12-10 | 2019-04-09 | Sigmapharm Laboratories, Llc | Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs |
EP3294745B1 (en) * | 2015-05-08 | 2020-01-01 | H. Hoffnabb-La Roche Ag | Novel oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection |
CN105943547B (zh) * | 2016-05-23 | 2018-01-19 | 北京慧宝源生物技术股份有限公司 | 抗hbv的药物组合物及其应用 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5684153A (en) | 1984-08-16 | 1997-11-04 | Beecham Group Plc | Process for the preparation of purine derivatives |
EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
US5223263A (en) | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
CS264222B1 (en) * | 1986-07-18 | 1989-06-13 | Holy Antonin | N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them |
JPH03501253A (ja) | 1987-09-22 | 1991-03-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | エイズ(aids)治療を目的とするリポソームによるヌクレオシド類似物質 |
US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
GB8904855D0 (en) * | 1989-03-03 | 1989-04-12 | Beecham Group Plc | Pharmaceutical treatment |
US5194654A (en) | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
US5411947A (en) | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
US5463092A (en) | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
US5914331A (en) | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US6346627B1 (en) | 1990-02-01 | 2002-02-12 | Emory University | Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers |
US5700937A (en) | 1990-02-01 | 1997-12-23 | Emory University | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
WO1991016920A1 (en) | 1990-05-07 | 1991-11-14 | Vical, Inc. | Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs |
JPH05507279A (ja) | 1990-05-29 | 1993-10-21 | ネクススター・ファーマシューティカルズ・インコーポレイテッド | グリセロールジ―およびトリホスフェート誘導体の合成 |
ES2083580T3 (es) | 1990-06-13 | 1996-04-16 | Arnold Glazier | Profarmacos de fosforo. |
US5674869A (en) * | 1990-07-07 | 1997-10-07 | Beecham Group Plc | Pharmaceutical treatment |
US5674849A (en) | 1990-10-24 | 1997-10-07 | Allelix Biopharmaceuticals Inc. | Anti-viral compositions |
US5256641A (en) | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
US5543389A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization | Covalent polar lipid-peptide conjugates for use in salves |
US5149794A (en) | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
US5179104A (en) | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5444063A (en) | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5925643A (en) | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
GB9104740D0 (en) | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
WO1992018517A1 (en) | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
GB9110874D0 (en) | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
EP0594677A4 (en) | 1991-07-12 | 1997-09-17 | Vical Inc | Antiviral liponucleosides: treatment of hepatitis b |
US5554728A (en) | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
GB9116601D0 (en) | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
US6177435B1 (en) | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
AU701574B2 (en) | 1993-05-12 | 1999-02-04 | Karl Y. Hostetler | Acyclovir derivatives for topical use |
US5587362A (en) | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
US5696277A (en) | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US5808040A (en) | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
WO1998023285A1 (en) * | 1996-11-29 | 1998-06-04 | Smithkline Beecham Plc | Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis b |
CA2287370C (en) * | 1997-03-19 | 2010-02-09 | Emory University | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
PT1382343E (pt) * | 1998-11-02 | 2010-03-10 | Gilead Sciences Inc | Terapia de combinação para tratamento do vírus da hepatite b |
-
1999
- 1999-11-02 PT PT03077543T patent/PT1382343E/pt unknown
- 1999-11-02 DK DK03077542T patent/DK1380303T3/da active
- 1999-11-02 DE DE69923338T patent/DE69923338T2/de not_active Expired - Lifetime
- 1999-11-02 ES ES99961553T patent/ES2237189T3/es not_active Expired - Lifetime
- 1999-11-02 DE DE69939604T patent/DE69939604D1/de not_active Expired - Lifetime
- 1999-11-02 CN CNB99814147XA patent/CN1173705C/zh not_active Expired - Fee Related
- 1999-11-02 AT AT03077543T patent/ATE457734T1/de active
- 1999-11-02 JP JP2000579237A patent/JP2002528508A/ja not_active Ceased
- 1999-11-02 EP EP03077542A patent/EP1380303B1/en not_active Expired - Lifetime
- 1999-11-02 AU AU18106/00A patent/AU1810600A/en not_active Abandoned
- 1999-11-02 ID IDW00200101179A patent/ID29471A/id unknown
- 1999-11-02 DK DK03077543.1T patent/DK1382343T3/da active
- 1999-11-02 US US09/432,247 patent/US6528515B1/en not_active Expired - Lifetime
- 1999-11-02 WO PCT/US1999/025673 patent/WO2000025797A1/en active Application Filing
- 1999-11-02 CN CNA2004100771301A patent/CN1666742A/zh active Pending
- 1999-11-02 IL IL14291099A patent/IL142910A0/xx unknown
- 1999-11-02 AT AT99961553T patent/ATE287268T1/de not_active IP Right Cessation
- 1999-11-02 EP EP03077543A patent/EP1382343B1/en not_active Expired - Lifetime
- 1999-11-02 EP EP99961553A patent/EP1124562B1/en not_active Expired - Lifetime
- 1999-11-02 CN CNA2006100999317A patent/CN1891221A/zh active Pending
- 1999-11-02 ES ES03077543T patent/ES2338642T3/es not_active Expired - Lifetime
- 1999-11-02 ES ES03077542T patent/ES2314157T3/es not_active Expired - Lifetime
- 1999-11-02 DE DE69942042T patent/DE69942042D1/de not_active Expired - Lifetime
- 1999-11-02 PT PT03077542T patent/PT1380303E/pt unknown
- 1999-11-02 AT AT03077542T patent/ATE408410T1/de active
- 1999-11-02 KR KR1020017005515A patent/KR100632520B1/ko not_active IP Right Cessation
-
2001
- 2001-05-01 IL IL142910A patent/IL142910A/en not_active IP Right Cessation
-
2003
- 2003-02-25 US US10/374,363 patent/US7572800B2/en not_active Expired - Fee Related
-
2004
- 2004-07-14 HK HK04105176.1A patent/HK1062146A1/xx not_active IP Right Cessation
-
2008
- 2008-07-31 IL IL193148A patent/IL193148A/en not_active IP Right Cessation
- 2008-12-10 CY CY20081101433T patent/CY1108635T1/el unknown
-
2009
- 2009-06-12 US US12/483,800 patent/US20090247487A1/en not_active Abandoned
-
2010
- 2010-04-30 CY CY20101100385T patent/CY1110629T1/el unknown
- 2010-11-11 JP JP2010252915A patent/JP2011079840A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110629T1 (el) | Πολυθεραπεια για θεραπευτικη αγωγη ιου ηπατιτιδας β | |
YU96192A (sh) | Trombin i postupak za njegovu proizvodnju | |
ATE329598T1 (de) | 1,3-oxathiolane zur behandlung von hepatitis | |
EA200600582A1 (ru) | Способы и композиции для лечения вирусного гепатита с | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
ATE346651T1 (de) | Nucleoside mit anti-hepatitis b virus wirksamkeit | |
ATE146968T1 (de) | Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie | |
BR9808221A (pt) | Método de tratamento de tumor. | |
ATE339211T1 (de) | L-fmau zur behandlung von hepatitis-delta-virus- infizierung | |
ATE150317T1 (de) | Synergische mischung zur behandlung von herpes | |
PT948967E (pt) | Tratamento de doencas virais em suicos | |
ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis | |
ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
ATE72115T1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a- | |
FI945035A (fi) | Pintasterilisointi laserkäsittelyn avulla | |
DE69006187D1 (de) | Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren. |